1. Home
  2. EXP vs SRRK Comparison

EXP vs SRRK Comparison

Compare EXP & SRRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eagle Materials Inc

EXP

Eagle Materials Inc

HOLD

Current Price

$204.41

Market Cap

7.0B

Sector

Industrials

ML Signal

HOLD

Logo Scholar Rock Holding Corporation

SRRK

Scholar Rock Holding Corporation

HOLD

Current Price

$46.81

Market Cap

5.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EXP
SRRK
Founded
1963
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Building Materials
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.0B
5.6B
IPO Year
1994
2018

Fundamental Metrics

Financial Performance
Metric
EXP
SRRK
Price
$204.41
$46.81
Analyst Decision
Hold
Strong Buy
Analyst Count
9
13
Target Price
$227.11
$56.17
AVG Volume (30 Days)
322.2K
1.3M
Earning Date
05-19-2026
05-07-2026
Dividend Yield
0.49%
N/A
EPS Growth
1.18
N/A
EPS
11.21
N/A
Revenue
$495,023,000.00
N/A
Revenue This Year
$1.97
N/A
Revenue Next Year
$1.95
$534.24
P/E Ratio
$18.80
N/A
Revenue Growth
N/A
N/A
52 Week Low
$171.99
$27.07
52 Week High
$243.64
$51.63

Technical Indicators

Market Signals
Indicator
EXP
SRRK
Relative Strength Index (RSI) 53.24 47.90
Support Level $202.49 $45.59
Resistance Level $240.80 $47.96
Average True Range (ATR) 5.93 1.67
MACD 0.56 -0.35
Stochastic Oscillator 53.98 25.92

Price Performance

Historical Comparison
EXP
SRRK

About EXP Eagle Materials Inc

Eagle Materials Inc produces and sells construction products and building materials. Construction products include cement, slag, concrete, and aggregates and building materials include cement and gypsum wallboard, and are sold to the construction and building industries. The firm organizes itself into two sectors: Heavy Materials, which includes the Cement and Concrete and Aggregates segments, and Light Materials, which includes the Gypsum Wallboard and Recycled Paperboard segments.

About SRRK Scholar Rock Holding Corporation

Scholar Rock Holding Corp is a biopharmaceutical company focused on improving the lives of children and adults with Spinal Muscular Atrophy and other rare, severe, and debilitating neuromuscular diseases. Its pipeline candidates include apitegromab and a subcutaneous formulation of apitegromab. The clinical-stage pipeline also includes SRK-439, an investigational subcutaneously administered fully human anti-pro/latent myostatin antibody with high inhibitory potency and selectivity toward myostatin, being developed for the treatment of rare neuromuscular diseases. The company also maintains early-stage programs focused on therapies for rare, severe, and debilitating neuromuscular diseases.

Share on Social Networks: